Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Prognostic impact of pre-transplant IPSS-m risk downstaging in Myelodysplastic Syndromes

Asmita Shukla, Jeff Justin Aguilar, Vikramjit Dhillon, Sikander Chohan, Nagasai Yalavarthi, Dakshin Padmanabhan, Sushmitha Nanja Reddy, Anisha Rajavel, Jay Yang, Jaroslaw Maciejewski, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 3872.

https://doi.org/10.1182/blood-2025-3872

Published: 2025

Journal Articles

Enhanced IPSS-m: A comorbidity-integrated model for improved clinical risk stratification in myelodysplastic neoplasms

Vikramjit Dhillon, Jeff Justin Aguilar, Sikander Chohan, Anisha Rajavel, Nagasai Yalavarthi, Dakshin Padmanabhan, Sushmitha Nanja Reddy, Yang Shi, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 3871.

https://doi.org/10.1182/blood-2025-3871

Published: 2025

Journal Articles

Deciphering clonal progression in MDS via longitudinal sequencing

Asmita Shukla, Jeff Justin Aguilar, Vikramjit Dhillon, Sikander Chohan, Nagasai Yalavarthi, Dakshin Padmanabhan, Sushmitha Nanja Reddy, Anisha Rajavel, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 2066.

https://doi.org/10.1182/blood-2025-2066

Published: 2025

Journal Articles

Multiomics-guided ex vivo drug sensitivity testing in Relapsed/Refractory Acute Myeloid Leukemia

Jeff Justin Aguilar, Vikramjit Dhillon, Sikander Chohan, Dakshin Padmanabhan, Sushmitha Nanja Reddy, Asmita Shukla, Nagasai Yalavarthi, Anisha Rajavel, Sonubar Virk, Breanna Williams, Julie Boerner, Yang Shi, Jay Yang, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 3496.

https://doi.org/10.1182/blood-2025-3496

Published: 2025

Journal Articles

Triple-negative myeloproliferative neoplasms (TN-MPN): A meta-analysis of clinical and molecular characteristics

Sushmitha Nanja Reddy, Jeff Justin Aguilar, Dakshin Padmanabhan, Henry Zou, Nagasai Yalavarthi, Asmita Shukla, Sandhya Dhiman, Guru Subramanian Guru Murthy, Clayton Jackson, Yazan Madanat, Julia Anderson, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 5603.

https://doi.org/10.1182/blood-2025-5603

Published: 2025

Journal Articles

The cachexia hematologic severity score (CHeSS): Use of a laboratory-based tool to predict survival and mutation-associated wasting in Acute Myeloid Leukemia and myelodysplastic syndrome

Sikander Chohan, Nagasai Yalavarthi, Jeff Justin Aguilar, Anisha Rajavel, Asmita Shukla, Sushmitha Nanja Reddy, Dakshin Padmanabhan, Vikramjit Dhillon, Asfar Azmi, Suresh Kumar Balasubramanian

Blood (2025) 146 (Supplement 1): 1735.

https://doi.org/10.1182/blood-2025-1735

Published: 2025

Journal Articles

Race does not impact chimeric antigen receptor T-cell therapy outcomes for multiple myeloma and diffuse large B cell lymphoma

Anisha Rajavel, Sushmitha Nanja Reddy, Saumya Karne, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Lois Ayash, Dipenkumar Modi, Andrew Kin, Joseph Uberti, Abhinav Deol

Blood (2025) 146 (Supplement 1): 6327.

https://doi.org/10.1182/blood-2025-6327

Published: 2025

Journal Articles

Outcomes of outpatient chimeric antigen receptor T-cell therapy administration: A single center experience at an urban hospital

Anisha Rajavel, Saumya Karne, Sushmitha Nanja Reddy, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Lois Ayash, Dipenkumar Modi, Andrew Kin, Joseph Uberti, Abhinav Deol

Blood (2025) 146 (Supplement 1): 6329.

https://doi.org/10.1182/blood-2025-6329

Published: 2025

Journal Articles

Race matters: Cytopenia trajectories after chimeric antigen receptor T- cell therapy in a single-center study

Sushmitha Nanja Reddy, Anisha Rajavel, Saumya Karne, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Andrew Kin, Lois Ayash, Joseph Uberti, Dipenkumar Modi, Abhinav Deol

Blood (2025) 146 (Supplement 1): 4170.

https://doi.org/10.1182/blood-2025-4170

Published: 2025

Journal Articles

Non-relapse mortality in patients who received CAR T-cell therapy at an urban hospital

Saumya Karne, Anisha Rajavel, Sushmitha Nanja Reddy, Janaka Liyanage, Seongho Kim, Jose Maciel Larios, Lois Ayash, Andrew Kin, Joseph Uberti, Dipenkumar Modi, Abhinav Deol

Blood (2025) 146 (Supplement 1): 4160.

https://doi.org/10.1182/blood-2025-4160

Published: 2025

Journal Articles

Clonal Evolution of TP53 Configurations with Treatment Predict Prognosis in Myeloid Neoplasms

Dakshin Padmanabhan, Jeff Aguilar, Paul Kim, Sandhya Dhiman, Asmita Shukla, Vikram Dhillon, Sushmitha Nanja Reddy, David Carr, Jay Yang, Julie Boerner, Jaroslaw Maciejewski, Suresh Kumar Balasubramanian

Blood (2024) 144 (Supplement 1): 1540.

https://doi.org/10.1182/blood-2024-210037

Published: 2024

Journal Articles

IPSS-M(r): A Reduced Feature Representation of IPSS-M for Clinical Application

Vikram Dhillon, Jeff Aguilar, Sandhya Dhiman, Dakshin Padmanabhan, Gregory Dyson, Suresh Kumar Balasubramanian, Sushmitha Nanja Reddy

Blood (2024) 144 (Supplement 1): 7499.

https://doi.org/10.1182/blood-2024-212356

Published: 2024

Journal Articles

Longitudinal Sequencing to Investigate Clonal Evolution in Myeloid Neoplasms

Asmita Shukla, Dakshin Padmanabhan, Paul Kim, Jeff Aguilar, Sushmitha Nanja Reddy, Vikram Dhillon, David Carr, Jay Yang, Julie Boerner, Suresh Kumar Balasubramanian

Blood (2024) 144 (Supplement 1): 4254.

https://doi.org/10.1182/blood-2024-212206

Published: 2024

Journal Articles

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Jeff Aguilar, Vikram Dhillon, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Julie Boerner, Gregory Dyson, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 6445.

https://doi.org/10.1182/blood-2023-190854

Published: 2023

Journal Articles

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Sushmitha Nanja Reddy, Jeff Aguilar, Lakshmi Bhavani Potluri, Vikram Dhillon, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian, Julie Boerner, Gregory Dyson

Blood (2023) 142 (Supplement 1): 6447.

https://doi.org/10.1182/blood-2023-189972

Published: 2023

Journal Articles

Concordance/Discordance of Paired Sequencing of Bone Marrow Tissue and Myeloid Sarcoma Samples- a Meta-Analysis

Dakshin Padmanabhan, Jeff Aguilar, Gregory Dyson, Lakshmi Bhavani Potluri, Vikram Dhillon, Sushmitha Nanja Reddy, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 6013.

https://doi.org/10.1182/blood-2023-190860

Published: 2023

Journal Articles

Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Gregory Dyson, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 822.

https://doi.org/10.1182/blood-2023-191336

Published: 2023

Journal Articles

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Lakshmi Bhavani Potluri, Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Dakshin Padmanabhan, Gregory Dyson, Julie Boerner, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 1853.

https://doi.org/10.1182/blood-2023-191277

Published: 2023

Journal Articles

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 4321.

https://doi.org/10.1182/blood-2023-191331

Published: 2023

Journal Articles

Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia

Abdul Moiz Khan, Sushmitha Nanja Reddy, Mai M M Aly, Vikram Dhillon, Ali Al Sbihi, Tariq Kewan, Waled Bahaj, Carmelo Gurnari, Bayan Al-Share, Gregory Dyson, Valeria Visconte, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 1433–1434.

https://doi.org/10.1182/blood-2022-165696

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Prognostic impact of pre-transplant IPSS-m risk downstaging in Myelodysplastic Syndromes

Enhanced IPSS-m: A comorbidity-integrated model for improved clinical risk stratification in myelodysplastic neoplasms

Deciphering clonal progression in MDS via longitudinal sequencing

Multiomics-guided ex vivo drug sensitivity testing in Relapsed/Refractory Acute Myeloid Leukemia

Triple-negative myeloproliferative neoplasms (TN-MPN): A meta-analysis of clinical and molecular characteristics

The cachexia hematologic severity score (CHeSS): Use of a laboratory-based tool to predict survival and mutation-associated wasting in Acute Myeloid Leukemia and myelodysplastic syndrome

Race does not impact chimeric antigen receptor T-cell therapy outcomes for multiple myeloma and diffuse large B cell lymphoma

Outcomes of outpatient chimeric antigen receptor T-cell therapy administration: A single center experience at an urban hospital

Race matters: Cytopenia trajectories after chimeric antigen receptor T- cell therapy in a single-center study

Non-relapse mortality in patients who received CAR T-cell therapy at an urban hospital

Clonal Evolution of TP53 Configurations with Treatment Predict Prognosis in Myeloid Neoplasms

IPSS-M(r): A Reduced Feature Representation of IPSS-M for Clinical Application

Longitudinal Sequencing to Investigate Clonal Evolution in Myeloid Neoplasms

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Concordance/Discordance of Paired Sequencing of Bone Marrow Tissue and Myeloid Sarcoma Samples- a Meta-Analysis

Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only